Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11866429 Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases

Patent 11866429 was granted and assigned to ChemoCentryx on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Rebecca M. Lui0

Darren J. McMurtrie0

Yibin Zeng0

Ryan J. Scamp0

Ju Yang0

Penglie Zhang0

Pingchen Fan0

Christopher W. Lange0

Date of Patent

January 9, 2024

0

Patent Application Number

170710560

Date Filed

October 15, 2020

0

Patent Citations

US Patent 10882833 Phenylate derivative, preparation method therefor, and pharmaceutical composition and uses thereof

0

US Patent 10919852 Immunomodulator compounds

0

US Patent 10941129 Benzyl phenyl ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

0

US Patent 10975049 Nicotinyl alcohol ether derivative, preparation method therefor, and pharmaceutical composition and uses thereof

0

US Patent 11059834 Macrocyclic immunomodulators

0

US Patent 11135210 Indane-amines as PD-L1 antagonists

0

US Patent 11266643 Triaryl compounds for treatment of PD-L1 diseases

0

US Patent 11304952 Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor

0

...

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11866429 Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.